Regarding colorectal cancer, FXYD1, FXYD3, and FXYD6 were significantly downregulated in the cancer samples, while FXYD4 and FXYD5 were overexpressed (P<0.05, fold change>1.5). Here, FXYD6 is linked to colorectal cancer.